En skanning, der med det samme kan forudse, om patientens kræft vil sprede sig, er om få år en realitet på danske sygehuse, skriver jp.dk
Det er danske forskere fra Rigshospitalet, der står i spidsen for det banebrydende forskningsprojekt.
Projektet, der i dag får 13,3 millioner kroner af Det Strategiske Forskningsråd, betyder, at lægerne hurtigt kan afgøre, om patienten straks skal have en aggressiv kræftbehandling, eller om det ikke er nødvendigt.
Det Strategiske Forskningsråd uddeler i alt 145 millioner kroner inden for sundehedsområdet.
Her er en oversigt over, hvem som modtager pengene:
Hans Erik Bøtker, Dr. Med, Ph.d. - Institut for Klinisk Medicin, Aarhus Universitet
Remote Protection Against Ischemia Reperfusion Injury in the Heart (REPAIR)
19,5 mio.
Andreas Kjær, Professor, Overlæge, Dr. Med. - Rigshospitalet, Dept. of Clinical Physiology, Nuclear Medicine & PET
Molecular imaging with PET for non-invasive tumor characterization and tailored cancer therapy: Translational studies.
13,3 mio. kr.
Allan Arthur Vaag, Professor, Chief Physician - Rigshospitalet, Department of Endocrinology
Fetal programming of type 2 diabetes (FEPRODI): Role of gestational diabetes, maternal and childhood nutrition, and epigenetic mechanisms
11,8 mio. kr.
Boye Lagerbon Jensen, MD, Dr. Med., Ph.D. , University of Southern Denmark - Institute of Molecular Medicine, Dept. of Cardiovascular and Renal Research
Hupp study – hypertension and urine protease activity in preeclampsia
12,3 mio. kr.
Gorm Greisen, Deputy head of the Institute of gynecology, obstetrics and paediatrics, Head of neonatology department, Professor of Paediatrics - Rigshospitalet, Københavns Universitetshospital
SafeBoosC: Safeguarding the brain of our smallest children – a feasibility randomised trial on near-infrared spectroscopy combined with treatment guideline in premature infants
11,1 mio. kr.
Allan Krasnik, M.D., MPH, PhD, Institut for Folkesundhedsvidenskab, Københavns Universitet
Towards Sustainable Healthy Lifestyles Interventions for Migrants
17,1 mio. kr.
Torben Hansen, MD, PhD, Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health Sciences, Københavns Universitet
TARGET - The impact of our genomes on individual treatment response in obese children
19,6 mio. kr.
Jens D. Mikkelsen, Afdelingslæge, Gruppeleder, Dr.Med. - Rigshospitalet, Neurobiologisk Forskningsenhed
Cognito - novel treatments of cognitive dysfunction
17,9 mio. kr.
Niels Møller, MD, Professor, Consultant Physician - Medical Research Laboratory, Clinical Institute of Medicine, Faculty of Health Sciences, Aarhus University
19,3 mio. kr.
